World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
8905
World Ranking
3653
National Ranking
34

Michael Theisen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael Theisen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 178 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael Theisen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Theisen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael Theisen is affiliated with the University of Copenhagen in Denmark and has focused their research primarily in the fields of Medicine and Immunology and Microbiology. Their scholarly work encompasses several subfields, notably Public Health, Environmental and Occupational Health, Immunology, Parasitology, Molecular Biology, and Epidemiology.

Theisen's research topics are centered significantly on infectious diseases, with particular attention to malaria research and control. Other main topics include mosquito-borne diseases and control, parasites and host interactions, the complement system in diseases, vaccines and immunoinformatics approaches, vector-borne infectious diseases, and HIV research and treatment.

Frequent coauthors in Theisen's publications include Susheel Kumar Singh, Bright Adu, Jordan Plieskatt, Mohammad Naghizadeh, and Asier Garcia-Senosiain.

Theisen has published extensively in various scientific journals. The most common publication venues are Frontiers in Immunology, Malaria Journal, Vaccine, American Journal of Tropical Medicine and Hygiene, and bioRxiv (Cold Spring Harbor Laboratory).

Some recent papers authored or coauthored by Theisen include:

  • Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity, 2021, Nature Communications
  • Neutrophils dominate in opsonic phagocytosis of P. falciparum blood-stage merozoites and protect against febrile malaria, 2021, Communications Biology
  • A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine, 2021, Frontiers in Immunology
  • Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine, 2021, npj Vaccines
  • Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2, 2021, PLoS neglected tropical diseases

Best Publications

  • Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements

    Else Marie Agger;Ida Rosenkrands;Jon Hansen;Karima Brahimi

  • Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.

    Christian Roussilhon;Claude Oeuvray;Christine Müller-Graf;Adama Tall

  • Antigenic Equivalence of Human T-Cell Responses to Mycobacterium tuberculosis-Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic Peptides

    Sandra M. Arend;Annemieke Geluk;Krista E. van Meijgaarden;Jaap T. van Dissel

  • Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies

    Matthias F Muellenbeck;Beatrix Ueberheide;Borko Amulic;Alexandra Epp

  • Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal

    Claude Oeuvray;Michael Theisen;Christophe Rogier;Jean-Francois Trape

  • Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa

    Issa Nebie;Amidou Diarra;Alphonse Ouedraogo;Issiaka Soulama

  • Association between Protection against Clinical Malaria and Antibodies to Merozoite Surface Antigens in an Area of Hyperendemicity in Myanmar: Complementarity between Responses to Merozoite Surface Protein 3 and the 220-Kilodalton Glutamate-Rich Protein

    Soe Soe;Michael Theisen;Christian Roussilhon;Khin-Saw Aye

  • Epitope Mapping of the Immunodominant Antigen TB10.4 and the Two Homologous Proteins TB10.3 and TB12.9, Which Constitute a Subfamily of the esat-6 Gene Family

    Rikke Louise Vinther Skjøt;Inger Brock;Sandra M. Arend;Martin E. Munk

  • The Glutamate-Rich Protein (GLURP) of Plasmodium falciparum Is a Target for Antibody-Dependent Monocyte-Mediated Inhibition of Parasite Growth In Vitro

    Michael Theisen;Soe Soe;Claude Oeuvray;Alan W. Thomas

  • Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

    Daniel Dodoo;Anastasia Aikins;Kwadwo Asamoah Kusi;Kwadwo Asamoah Kusi;Helena Lamptey

  • Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.

    M Theisen;J Vuust;A Gottschau;S Jepsen

  • Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen.

    M Theisen;B Frederiksen;A M Lebech;J Vuust

  • Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate.

    Meral Esen;Peter G. Kremsner;Regina Schleucher;Michael Gässler

  • Naturally Acquired Antibodies to the Glutamate-Rich Protein Are Associated with Protection against Plasmodium falciparum Malaria

    Daniel Dodoo;Daniel Dodoo;Michael Theisen;Jørgen A. L. Kurtzhals;Jørgen A. L. Kurtzhals;Bartholomew D. Akanmori

  • Analysis of the OspE Determinants Involved in Binding of Factor H and OspE-Targeting Antibodies Elicited during Borrelia burgdorferi Infection in Mice

    Michael S. Metts;John V. McDowell;Michael Theisen;Paul Robert Hansen

  • A Plasmodium falciparum GLURP–MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies

    Michael Theisen;Soe Soe;Katja Brunstedt;Frank Follmann

  • Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.

    Cornelus C. Hermsen;Danielle F. Verhage;Denise S.C. Telgt;Karina Teelen

  • A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.

    Sodiomon B Sirima;Benjamin Mordmüller;Paul Milligan;Ulysse Ateba Ngoa

  • Recent advances in recombinant protein-based malaria vaccines.

    Simon J. Draper;Evelina Angov;Toshihiro Horii;Louis H. Miller

  • Identification and characterization of a 29-kilodalton protein from Mycobacterium tuberculosis culture filtrate recognized by mouse memory effector cells.

    Ida Rosenkrands;Peter Birk Rasmussen;Markus Carnio;Susanne Jacobsen

  • Identification of a Conserved Region of Plasmodium falciparum MSP3 Targeted by Biologically Active Antibodies to Improve Vaccine Design

    Subhash Singh;Soe Soe;Juan-Pedro Mejia;Christian Roussilhon

Frequent Co-Authors

Michael Christiansen
Michael Christiansen Statens Serum Institut
Benjamin Mordmüller
Benjamin Mordmüller Radboud University Medical Center
Robert W. Sauerwein
Robert W. Sauerwein Radboud University
Pierre Druilhe
Pierre Druilhe Institut Pasteur
Peter G. Kremsner
Peter G. Kremsner University of Tübingen
Peter E. Andersen
Peter E. Andersen Technical University of Denmark
Teun Bousema
Teun Bousema Radboud University
Saadou Issifou
Saadou Issifou University of Tübingen
Giampietro Corradin
Giampietro Corradin University of Lausanne
Ayola A. Adegnika
Ayola A. Adegnika University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Immunology in the USA, exploring related healthcare degrees can broaden career opportunities. Many professionals transition into nursing roles where immunology knowledge is highly valued. For those considering a swift entry, accelerated nursing programs offer a faster track to becoming a registered nurse, ideal for immunology graduates seeking clinical roles.

Entry-level nursing positions, such as Licensed Practical Nurses, can also be accessed through lpn programs easy to get into, presenting a straightforward pathway to healthcare employment. For more advanced practice, which nurse practitioner program is easiest investigates programs balancing accessibility and quality, suitable for immunology students pursuing advanced patient care roles.

Mental health is another growing sector where immunology intersects, making pmhnp programs online with best clinical placement valuable for those targeting psychiatric mental health nurse practitioner careers. These programs ensure strong clinical experience while offering flexibility for working students.

Overall, combining immunology expertise with nursing credentials through accessible online programs can enhance career prospects in diverse healthcare settings.

Best Scientists Citing Michael Theisen

Trending Scientists

Recently Published Articles